Iprasol is a preperation of Salbutamol & Ipratropium bromide.Salbutamol is a beta2-adrenergic agent which acts on airway smooth muscle resulting in relaxation. Ipratropium Bromide is a anticholinergic agent that works as a bronchodilator that dilates the bronchi in the lungs. Iprasol provides the simultaneous release of ipratropium bromide and salbutamol allowing the synergistic efficacy on the muscarinic and beta2-adrenergic receptors in the airways to cause bronchodilation which is superior to that provided by each single agent and with no potentiation of adverse events.
- Dual mechanism of action offers more bronchodilation than Salbutamol and Ipratropium alone in specific situations
- Reduces hypersecretion and increase bronchial muscle tone through anticholinergic pathway
- An effective and safe alternative to Nebulizer as emergency treatment both at home and emergency department (with large volume spacer)
- Two therapy in one inhaler increases patients’ compliance